Superoxide dismutase mimetics: Possible clinical applications;Mimetyki dysmutazy ponadtlenkowej-potencjalne zastosowania kliniczne

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 613-624

  Woźniak, Michał ^a   Czyz, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Reactive oxygen species; Superoxide; Superoxide dismutase mimetics

Indexed keywords

BIOMIMETIC MATERIAL; ISOPROTEIN; PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

AGING; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DISEASE MODEL; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

AGING; ANIMALS; BIOMIMETIC MATERIALS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; PROTECTIVE AGENTS; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 60649092808     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. Aggarwal B.B., Kumar A., Bharti, A.C.: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res., 2003; 23: 363-398
2. Alexandre J., Nicco C., Chereau C., Laurent A., Weill B., Goldwasser F., Batteux F.: Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J. Natl. Cancer Inst., 2006; 98: 236-244
3. Alli S.S., Hardt J.I., Quick K.L., Kim-Han J.S., Erlanger B.F., Huang T.T., Epstein C.J., Dugan L.L.: A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic. Biol. Med., 2004; 37: 1191-1202
4. Archibald F.S., Fridovich I.: The scavenging of superoxide radical by manganous complexes: in vitro. Arch. Biochem. Biophys., 1982; 214: 452-463
5. Asaba K., Tojo A., Onozato M.L., Goto A., Fujita T.: Double-edged action of SOD mimetic in diabetic nephropathy. J. Cardiovasc. Pharmacol., 2007; 49: 13-19
6. Baker K., Marcus C.B., Huffman K., Kruk H., Malfroy B., Doctrow S.R.: Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic brain injury. J. Pharmacol. Exp. Ther., 1998; 284: 215-221
7. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burlow D.L., Conklin C.A., Hu Z., Reuf J., Horaist C., Lebovitz R., Hunter G.C., McIntyre K., Runge M.S.: Mitochondrial integrity and function in atherogenesis. Circulation, 2002; 106: 544-549
8. Barika A., Mishraa B., Shenb L., Mohana H., Kadamc R.M., Duttad S., Zhangb H.Y., Priyadarsini K.I.: Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions Free Radic. Biol. Med., 2005; 39: 811-822
9. Bartosz G.: Druga twarz tlenu. Wolne rodniki w przyrodzie. Wyd. Naukowe PWN, Warszawa 2003, wyd. 2
10. Baum L., Ng A.: Curcumin interaction with copper and iron suggest one possible mechanism of action in Alzheimer's disease animals models. J. Alzheimers Dis., 2004; 6: 367-377
11. Bedda S., Laurent A., Conti F., Chéreau C., Tran A., Tran-Van Nhieu J., Jaffray P., Soubrane O., Goulvestre C., Calmus Y., Weill B., Batteux F.: Manafodipir prevents liver injury induced by acetaminophen in the mouse. J. Hepatol. 2003; 39: 765-972
12. Beyer W.F., Fridovich I.: Superoxide dismutase mimic prepared from desferrioxamine and manganese dioxide. Methods. Enzymol., 1990; 186: 242-249
13. Boka B., Myari A., Sovago I., Hadjiliadis N.: Copper(II) and zinc(II) complexes of the peptides Ac-HisValHis-NH2 and Ac-HisValGlyAsp-NH2 related to the active site of the enzyme CuZnSOD. J. Inorg. Chem., 2004; 98: 113-122
14. Bruce A.J., Malfroy B., Baudry M.: β-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA, 1996; 93: 2312-2316
15. Brurok H., Ardenkjaer-Larsen J.H., Hansson G., Skarra S., Berg K., Karlsson J.O.G, Laursen I., Jynge P.: Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? In vitro and ex vivo assessments. Biochem. Biophys. Res. Commun., 1999; 254: 768-772
16. Buetler T.M., Krauskopf A., Ruegg U.T.: Role of superoxide as a signaling molecule. News Physiol. Sci., 2004; 19: 120-123
17. Carroll R.T., Galatsis P., Borosky S., Kopec K.K., Kumar V., Althaus J.S., Hall E.D.: 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration. Chem. Res. Toxicol., 2000; 13: 294-300
18. Chae H.J., Kim H.R., Kim D.S., Woo E.R., Cho Y.G., Chae S.W.: Saeng-Ji-Hwang has a protective effect on adriamycin-induced cytotoxicity in cardiac muscle cells. Life Sci., 2005; 76: 2027-2042
19. Charloux C., Paul M., Loisance D., Astier A.: Inhibition of hydroxyl radical produced by lactobionate, adenine, and tempol. Free Radic. Biol. Med., 1995; 19: 669-704
20. Chen Y.F., Cowley A.W., Zou A.P.: Increased H2O2 counters the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2003; 285: R827.R833
21. Cheung E.C., Melanson-Drapeau L., Cregan S.P., Vanderluit J.L., Ferguson K.L., McIntosh W.C., Park D.S., Bennett S.A., Slack R.S.: Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J. Neurosci., 2005; 25: 1324-1334
22. Cuzzocrea S., Genovese T., Mazzon E., Di Paola R., Muia C., Britti D., Salvemini D.: Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic. Shock, 2004; 22: 254-261
23. Cuzzocrea S., Misko T.P., Costantino G., Mazzon E., Micali A., Caputi A.P., Macarthur H., Salvemini D.: Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J, 2000; 14: 1061-1072
24. Cuzzocrea S., Zingarelli B., Caputi A.P.: Role of constitutive nitric oxide synthase activation and peroxynitrite production in a rat mode of splanchnic artery occlusion shock. Life Sci., 1998; 63: 789-800
25. Day B.J., Batinic-Haberle I., Crapo J.D.: Metalloporphyrins are potent inhibitors of lipid peroxidation. Free Radic. Biol. Med., 1999; 26: 730-736
26. DeFreitas-Silva G., Reboucas J.S., Spasojevi. I., Benov L., Idemori Y.M., Batini.-Haberle I.: SOD-like activity of Mn(II) beta-octabromo-meso-tetrakis(N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself. Arch. Biochem. Biophys., 2008: 477: 105-112
27. Doctrow S.R., Huffman K., Marcus C.B., Musleh W., Bruce A., Baudry M., Malfroy B.: Salen-manganese complexes: combined superoxide dismutase/catalase mimics withbroad pharmacological efficacy. Adv. Pharmacol., 1997; 38: 247-269
28. Elchuri S., Oberley T.D., Qi W., Eisenstein R.S., Jackson Roberts L., Van Remmen H., Epstein C.J., Huang T.T.: CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene, 2005; 24: 367-380
29. Faraci F.M., Didion S.P.: Vascular protection: superoxide dismutase isoforms in the vessel wall. Arteriosler. Thromb. Vasc. Biol., 2004; 24: 1367-1373
30. Faulkner K.M., Liochev S.I., Fridovich I.: Stable Mn(III) porphiryns mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem., 1994; 269: 23471-23476
31. Fisher A.E.O, Lau G., Naughton D.P.: Lipophilic ionophore complexes as superoxide dismutase mimetics. Biochem. Biophys. Res. Commun., 2005; 329: 930-933
32. Fucassi F., Lowe, J.E., Pavey K.D., Shah S., Faragher R.G., Green M.H., Paul F., O'Hare D., Cragg P.J.: a-Lipoic acid and glutathione protect against the prooxidant activity of SOD/catalase mimetic manganese salen derivatives. J. Inorg. Biochemistry, 2007; 101: 225-232
33. Galinanes M., Ferrari R., Qiu Y., Cargnoni A., Ezrin A., Hearse D.J.: PEG-SOD and myocardial antioxidant status during ischaemia and reperfusion: dose-response studies in the isolated blood perfused rabbit heart. J. Mol. Cell. Card., 1992; 24: 1021-1030
34. Guo Z.M., Van Remmen H., Yang H., Chen X., Mele J., Vijg J., Epstein C.J., Ho Y.S., Richardson A.: Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arterioscler. Thromb. Vasc. Biol., 2001; 21: 1131-1138
35. Hahn S.M., Krishna C.M., Samuni A., Mitchell J.B., Russo A.: Mn(III)-desferrioxamine superoxide dismutase-mimic: alternative modes of action. Arch. Biochem. Biophys., 1991; 288: 215-219
36. Halliwell B., Gutteridge J.M.: Free radicals in biology and medicine. Oxford, UK, Oxford University Press, 1999
37. Hao J., Li H., Liu W., Hirsch A.: Well-defined self-assembling supramolecular structures in water containing a small amount of C60. Chem. Commun., 2004: 602-603
38. Hemdan S., Almazan G.: Deficient peroxide detoxification underlies the susceptibility of oligodendrocyte progenitors to dopamine toxicity. Neuropharmacology, 2007; 52: 1385-1395
39. Higashi N., Shosu T., Koga T., Niwa M., Tanigawa T.: pH-responsive, self-assembling nanoparticle from a fullerene-tagged poly(L-glutamic acid) and its superoxide dismutase mimetic property. J. Colloid Interface Sci., 2006; 298: 118-123
40. Hsu T.C., Young M.R., Cmarik J., Colburn N.H.: Activator protein 1 (AP-1)-and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med., 2000; 28: 1338-1348
41. Huang T.T., Carlson E.J., Kozy H.M., Mantha S., Goodman S.I., Ursell P.C., Epstein C.J.: Genetic modification of prenatal lethality and dilated cardiomyopathy in Mn superoxide dismutase mutant mice. Free Radic. Biol. Med., 2001; 31: 1101-1100
42. Jiang F., Guo Y., Salvemini D., Dusting G.J.: Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice. Br. J. Pharmacol., 2003; 139: 1127-1134
43. Johnson F, Giulivi C.: Superoxide dismutases and their impact upon human health. Mol. Aspects. Med. 2005; 26: 340-352
44. Jung O., Marklund S.L., Geiger H., Pedrazzini T., Busse R., Brandes R.P.: Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability. In vivo and ex vivo evidence from ecSODdeficient mice. Circ. Res, 2003; 93: 622-629
45. Karlsson J.O., Brurok H., Eriksen M., Towart R., Toft K.G., Moen O., Engebretsen B., Jynge P., Refsum H.: Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol., 2001; 42: 540-547
46. Konorev E.A., Kennedy M.C., Kalyanaraman B.: Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: The role of reactive oxygen and nitrogen intermediates. Arch. Biochem. Biophys., 1999; 368: 421-428
47. Koo D.D., Welsh K.I., West N.E., Channon K.M., Penington A.J., Roake J.A., Morris P.J., Fuggle S.V.: Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase. Kidney Int., 2001; 60:786-796
48. Krishna M.C., Grahame D.A., Samuni A., Mitchell J.B., Russo A.: Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc. Natl. Acad. Sci. USA, 1992; 89: 5537-5541
49. Krusic P., Wasserman E., Keizer P.N., Morton J.R., Preston K.F.: Radical reactions of C60. Science, 1991; 254: 1183-1185
50. Kuppusamy P., Wang P., Shankar R.A., Ma L., Trimble C.E., Hsia C.J., Zweier J.L.: In vivo topical EPR spectroscopy and imaging of nitroxide free radicals and polynitroxyl-albumin. Magn. Reson. Med., 1998; 40: 806-811
51. Lassegue B., Clempus R.E.: Vascular NAD(P)H oxidases: specific features, expression and regulation. Am. J. Psychiol. Regul. Integr. Comp. Physiol., 2003; 285: R277.R297
52. Laurent A., Nicco C., Chereau C. Goulvestre C., Alexandre J., Alves A., Levy E., Goldwasser F., Panis Y., Soubrane O., Weill B., Batteux F.: Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res., 2005; 65: 948-956
53. Lee B.I., Chan P.H., Kim G.W.: Metalloporphyrin-based superoxide dismutase mimic attenuates the nuclear translocation of apoptosis-inducing factor and the subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. Stroke, 2005; 36: 2712-2717
54. Lee J., Hunt J.A., Groves J.T.: Manganese porphyrins as redox-coupled peroxynitrite reductases. J. Am. Chem. Soc., 1998; 120: 6053-6061
55. Levin E.D., Christopher N.C., Crapo J.D.: Memory decline of aging reduced by extracellular superoxide dismutase overexpression. Behav. Genet., 2005; 35: 447-453
56. Liang Q., Smith A.D., Pan S.,Tyurin V.A.,Kagan V.E., Hastings T.G., Schor N.F.: Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem. Pharm., 2005; 70: 1371-1381
57. Liu B., Gao H.M., Wang J.Y., Jeohn G.H., Cooper C.L., Hong J.S.: Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. NY Acad. Sci., 2002; 962: 318-331
58. Lopez-Lazaro M.: Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy. Cancer Lett., 2007; 252: 1-8
59. Marberger H., Huber W., Bartsch G., Schulte T., Swoboda P.: ORGOTEIN: A new antiinflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract. Int Urol. Nephrol., 1974; 6: 61-74
60. Marklund S.L.: Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA, 1982; 79: 7634-7638
61. Masini E., Cuzzocrea S., Mazzon E., Marzocca C., Mannaioni P.F., Salvemini D.: Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo. Br. J. Pharmacol., 2002; 136: 905-917
62. Melov S., Doctrow S.R., Schneider J.A., Haberson J., Patel M., Coskun P.E., Huffman K., Wallace D.C., Malfroy B.: Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci., 2001; 21: 8348-8353
63. Metz J.M.,Smith D., Mick R., Lustig R.,Mitchell J., Cherakuri M., Glatstein E., Hahn S.M.: A phase I study of topical tempol for the prevention of alopecia induced by whole brain radiotherapy. Clinic. Cancer Res., 2004; 10: 6411-6417
64. Murata S., Miniati D.N., Kown M.H., Koransky M.L., Lijkwan M.A., Balsam L.B., Robbins R.C.: Superoxide dismutase mimetic M40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts. Transplantation., 2004; 78: 1166-1171
65. Muscoli C., Cuzzocrea S., Riley D.P., Zweier J.L., Thiemermann C., Wang Z. Q., Salvemini D.: On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol., 2003; 140: 445-460
66. Nilakantan V., Zhou X., Hilton G., Shi Y., Baker J.E., Khanna A.K., Pieper G.M.: Antagonizing reactive oxygen by treatment with a manganese (III) metalloporphyrin-based superoxide dismutase mimetic in cardiac transplants. J. Thorac. Cardiovasc. Surg., 2006; 131: 898-906
67. Packer L.: Methods in Enzymology, t. 349 Superoxide Dismutase, California Academic Press, San Diego 2002
68. Passerini A.G., Polacek D.C., Shi C., Francesco N.M., Manduchi E., Grant G.R., Pritchard W.F., Powell S., Chang G.Y., Stoeckert C.J., Davies P.F.: Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc. Natl. Acad. Sci., 2004; 101: 2482-2487
69. Penninger J.M., Kroemer G.: Mitochondria, AIF and caspases-rivaling for cell death execution. Nat. Cell Biol., 2003; 5: 97-99
70. Pieper G.M., Nilakantan V., Nguyen T.K., Hilton G., Roza A.M., Johnson C.P.: Reactive oxygen and reactive nitrogen as signaling molecules for caspase 3 activation in acute cardiac transplant rejection. Antioxid. Redox. Signal., 2008; 10: 1031-1040
71. Pong K., Doctrow S. R., Baudry M.: Prevention of 1-methyl-4-phenylpyridinium and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons. Brain Res., 2000; 881: 182-189
72. Quick K.L., Ali S.S., Arch R., Xiong C., Wozniak D., Dugan L.L: A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol. Aging, 2008; 29: 117-128
73. Radi R., Cassina A., Hodara R., Quijano C., Castro L.: Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med., 2002; 33: 1451-1464
74. Rebouças J.S., DeFreitas-Silva G., Spasojeviæ I., Idemori Y.M., Benov L., Batiniæ-Haberle I.: Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier. Free Radic. Biol. Med., 2008; 45: 201-210
75. Rhee S.G.: Redox signaling: hydrogen peroxide as an intracellular messenger. Exp. Mol. Med., 1999; 31: 53-59
76. Riedl C.R., Sternig P., Gallé G., Langmann F., Vcelar B., Vorauer K., Wagner A., Katinger H., Pflüger H.: Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: A randomized placebo-controlled double-blind prospective clinical study. Eur. Urol., 2005; 48: 656-661
77. Salvemini D., Mazzon E., Dugo L., Riley D.P., Serraino I., Caputi A.P., Cuzzocrea S.: Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br. J. Pharmacol., 2001; 132: 815-827
78. Salvemini D., Wang Z.Q., Zweier J.L., Samouilov A., Macarthur H., Misko T.P., Currie M.G., Cuzzocrea S., Sikorski J.A., Riley D.P.: A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science, 1999; 286: 304-306
79. Samai M., Sharpe M.A., Gard P.R., Chatterjee P.K.: Comparison of the effects of the superoxide dismutase mimetics EUK-134 and tempol on paraquat-induced nephrotoxicity. Free Radic. Biol. Med., 2007;43: 528-534
80. Samlowski W.E., Petersen R., Cuzzocrea S., Macarthur H., Burton D., McGregor J.R., Salvemini D.: Nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects. Nat. Med., 2003; 9: 750-755
81. Sedeek M.H., Llinas M.T., Drummond H, Fortepiani L., Abram S.R., Alexander B.T., Reckelhoff J.F., Granger J.P.: Role of reactive oxygen species in endothelin-induced hypertension. Hypertension, 2003; 42: 806-810
82. Sharma S.S., Gupta S.: Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation. Eur. J. Pharm., 2007; 561: 72-79
83. Shimizu K., Rajapakse N., Horiguchi T., Payne R.M., Busija D.W.: Protective effect of a new nonpeptidyl mimetic of SOD, M40401, against focal cerebral ischemia in the rat. Brain Res., 2003; 963: 8-14
84. Skrzycki M., Czeczot H.: Superoxide dismutase as a potential therapeutic agent. Adv. Clin. Exp. Med., 2007; 16: 561-568
85. Suzuki J, Broeyer F, Cohen A, Takebe M, Burggraaf J, Mizushima Y.: Pharmacokinetics of PC-SOD, a lecithinized recombinant superoxide dismutase, after single-and multiple-dose administration to healthy Japanese and Caucasian volunteers. J. Clin. Pharmacol., 2008; 48: 184-192
86. Szabo C., Day B.J., Salzman A.L.: Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages, using a novel mesoporphyrin superoxide dismutase analog and peroxynitrite scavenger. FEBS Lett., 1996; 381: 82-86
87. Tanaka K., Kogawa K., Nishihori Y., Kuribayashi K., Nakamura K., Muramatsu H., Koike K., Sakamaki S., Niitsu Y.: Suppression of intracellular Cu-Zn SOD results in enhanced motility and metastasis of Meth A sarcoma cells. Int. J. Cancer, 1997; 73: 187-192
88. Taniyama Y., Griendling K.K.: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension, 2003; 42: 1075-1081
89. Tao L., Jiao X., Gao E., Lau W.B., Yuan Y., Lopez B., Christopher T., RamachandraRao S.P., Williams W., Southan G., Sharma K., Koch W., Ma X.L.: Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation, 2006; 114: 1395-1402
90. Thiels E., Urban N.N., Gonzalez-Burgos G.R., Kanterewicz B.I., Barrionuevo G., Chu C.T., Oury T.D., Klann E.: Impairment of longterm potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci., 2000; 20: 7631-7639
91. Thiemermann C.: Membrane-permeable radical scavengers (Tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit. Care Med., 2003; 31: S76-S84
92. Tian Y., Fang Y.Z., Sun C.P., Shen W.M., Luo Q.H., Shen M.C.: Effects of copper coordinate complexes on the scavenging of reactive oxygen species. Biochem. Biophys. Res. Commun., 1993; 191: 646-653
93. Tumurkhuu G., Koide N., Dagvadorj J., Hassan F., Islam S., Naiki Y., Mori I., Yoshida T., Yokochi T.: MnTBAP, a synthetic metalloporphyrin, inhibits production of tumor necrosis factor-alpha in lipopolysaccharide-stimulated RAW 264-7 macrophages cells via inhibiting oxidative stress-mediating p38 and SAPK/JNK signaling. FEMS Immunol. Med. Microbiol., 2007; 49: 304-311
94. Turpaev K.T.: Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc), 2002; 67: 281-292
95. Turrens J.F.: Mitochondrial formation of reactive oxygen species. J. Psychiol., 2003; 552: 335-344
96. Van Remmen H., Ikeno Y., Hamilton M., Pahlavani M., Wolf N., Thorpe S.R., Alderson N.L., Baynes J.W., Epstein C.J., Huang T.T., Nelson J., Strong R., Richardson A.: Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics, 2003; 16: 29-37
97. Veronese F.M., Caliceti P., Schiavon O., Sergi M.: Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv. Drug Deliv. Rev., 2002; 54: 587-606
98. Wang T., Liu B., Qin L., Wilson B., Hong J.S.: Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures. J. Neuroimmunol., 2004; 147: 68-72
99. Wangila G.W., Nagothu K.K., Steward R. III, Bhatt R., Iyere P.A., Willingham W.M., Sorenson J.R., Shah S.V., Portilla D.: Prevention of cisplatin-induced kidney epithelial cell apoptosis with a Cu superoxide dismutase-mimetic [copper2II(3,5-ditertiarybutylsalicylate)4(ethanol) 4]. Toxicol. In Vitro, 2006; 20: 1300-1312
100. Xu H., Fink G.D., Galligan J.J.: Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2-in DOCA-salt rats. Hypertension, 2004; 43: 329-334
101. Yang J., Li L., Wang C.: Synthesis of a water soluble, monosubstituted C60 polymeric derivative and its photoconductive properties. Macromol., 2003; 36: 6060-6065
102. Yang P.M., Chiu S.J., Lin L.Y.: Differential effects of salen and manganese-salen complex (EUK-8) on the regulation of cellular cadmium uptake and toxicity. Toxicol. Sci., 2005; 85: 551-559
103. Zabłocka A., Janusz M.: The two faces of reactive oxygen species. Post. Hig. Med. Dos̈w., 2008; 62: 118-124
104. Zelko I.N., Mariani T.J., Folz R.J.: Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med., 2002; 33: 337-349
105. Zhang Y., Zhao W., Zhang H.J., Domann F.E., Oberley L.W.: Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res., 2002; 62: 1205-1212